| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.2M | -32.6% |
| Cost of Revenue | $2.7M | -22.9% |
| R&D Expense | $12.9M | +23.6% |
| SG&A Expense | $17.2M | +2.1% |
| Operating Income | -$32.4M | -20.4% |
| Pre-tax Income | $7.5M | +110.3% |
| Income Tax | -$2.5M | — |
| Net Income | $10.0M | +113.8% |
| EPS (Basic) | $0.26 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $18.2M | -41.6% |
| Short-term Investments | $28.8M | +224.6% |
| Accounts Receivable | $1.1M | +687.3% |
| Inventory | $339K | +377.5% |
| Current Assets | $52.6M | +23.0% |
| Total Assets | $95.7M | +70.1% |
| Current Liabilities | $5.7M | +27.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$27.6M | -22.1% |
| Capital Expenditures | $713K | +169.1% |
| Investing Cash Flow | -$24.6M | -457.4% |
| Financing Cash Flow | $39.2M | +64.9% |
| Free Cash Flow | -$28.4M | -23.8% |
| +109.6% |
| EPS (Diluted) | $0.24 | +108.9% |
| Total Liabilities |
| $21.0M |
| -68.0% |
| Stockholders' Equity | $74.7M | +883.3% |